Elevate Capital Advisors LLC acquired a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,135 shares of the company's stock, valued at approximately $834,000.
A number of other large investors also recently bought and sold shares of the company. Brooklyn Investment Group raised its position in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in Clorox during the third quarter valued at $27,000. Continuum Advisory LLC raised its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after purchasing an additional 138 shares during the period. Carolina Wealth Advisors LLC bought a new position in shares of Clorox in the 3rd quarter worth about $48,000. Finally, Friedenthal Financial acquired a new position in shares of Clorox in the 3rd quarter valued at about $49,000. Institutional investors own 78.53% of the company's stock.
Clorox Price Performance
Shares of NYSE:CLX traded up $2.12 during trading on Thursday, reaching $150.77. The company had a trading volume of 1,146,565 shares, compared to its average volume of 1,334,095. The firm's fifty day moving average is $159.93 and its 200 day moving average is $159.19. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The firm has a market capitalization of $18.66 billion, a PE ratio of 41.19, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.
Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the business earned $2.16 earnings per share. On average, equities analysts forecast that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.24%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox's dividend payout ratio (DPR) is presently 133.33%.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on CLX shares. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Barclays increased their target price on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research report on Wednesday, February 5th. Finally, Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Clorox presently has an average rating of "Hold" and a consensus price target of $158.21.
Read Our Latest Stock Report on CLX
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.